Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Buchkremer

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Dialogues in Clinical Neuroscience|April 28, 2006
The German Research Network on Schizophrenia--impact on the management of schizophreniaWolfgang Wölwer, Anja Baumann, Andreas Bechdolf, et al.
Journal of Psychiatric Research|April 8, 2006
Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressantsChristoph Laske, Elke Stransky, Gerhard W Eschweiler, et al.
Journal of Psychiatric Research|March 24, 2006
BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controlsChristoph Laske, Elke Stransky, Thomas Leyhe, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie|April 8, 2009
[Research into the feasibility of cognitive behavioural therapy in the treatment of psychotic disorders]Stefan Klingberg, Andreas Wittorf, Andreas Bechdolf, et al.
The Journal of Nervous and Mental Disease|July 9, 2010
Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?Andreas Wittorf, Ute E Jakobi, Kerstin K Bannert, et al.
Biological Psychiatry|December 19, 2002
A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic functionMichael D Köhnke, Cyrus P Zabetian, George M Anderson, et al.
Trials|December 31, 2010
Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: the POSITIVE Study, a multicenter, prospective, single-blind, randomised controlled clinical trialStefan Klingberg, Andreas Wittorf, Christoph Meisner, et al.
The International Journal of Neuropsychopharmacology|May 10, 2008
Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on SchizophreniaHans-Jürgen Möller, Michael Riedel, Markus Jäger, et al.
Plos One|April 7, 2015
Alpha-synuclein levels in blood plasma decline with healthy agingNiklas K U Koehler, Elke Stransky, Mirjam Meyer, et al.
Psychiatry Research|February 19, 2008
Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment responseMarkus Jäger, Michael Riedel, Max Schmauss, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Dialogues in Clinical Neuroscience|April 28, 2006
The German Research Network on Schizophrenia--impact on the management of schizophreniaWolfgang Wölwer, Anja Baumann, Andreas Bechdolf, et al.
Journal of Psychiatric Research|April 8, 2006
Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressantsChristoph Laske, Elke Stransky, Gerhard W Eschweiler, et al.
Journal of Psychiatric Research|March 24, 2006
BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controlsChristoph Laske, Elke Stransky, Thomas Leyhe, et al.
Psychotherapie, Psychosomatik, Medizinische Psychologie|April 8, 2009
[Research into the feasibility of cognitive behavioural therapy in the treatment of psychotic disorders]Stefan Klingberg, Andreas Wittorf, Andreas Bechdolf, et al.
The Journal of Nervous and Mental Disease|July 9, 2010
Does the cognitive dispute of psychotic symptoms do harm to the therapeutic alliance?Andreas Wittorf, Ute E Jakobi, Kerstin K Bannert, et al.
Biological Psychiatry|December 19, 2002
A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: evidence for alcohol-related differences in noradrenergic functionMichael D Köhnke, Cyrus P Zabetian, George M Anderson, et al.
Trials|December 31, 2010
Cognitive behavioural therapy versus supportive therapy for persistent positive symptoms in psychotic disorders: the POSITIVE Study, a multicenter, prospective, single-blind, randomised controlled clinical trialStefan Klingberg, Andreas Wittorf, Christoph Meisner, et al.
The International Journal of Neuropsychopharmacology|May 10, 2008
Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on SchizophreniaHans-Jürgen Möller, Michael Riedel, Markus Jäger, et al.
Plos One|April 7, 2015
Alpha-synuclein levels in blood plasma decline with healthy agingNiklas K U Koehler, Elke Stransky, Mirjam Meyer, et al.
Psychiatry Research|February 19, 2008
Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment responseMarkus Jäger, Michael Riedel, Max Schmauss, et al.
Pageof 5